BIO-RAD LABORATORIES, INC. (BIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q3 '16: 2.1B Q4 '16: 2.1B Q1 '17: 2.1B Q2 '17: 2.1B Q3 '17: 2.1B Q4 '17: 2.2B Q1 '18: 2.2B Q2 '18: 2.3B Q3 '18: 2.3B Q4 '18: 2.3B Q1 '19: 2.3B Q2 '19: 2.3B Q3 '19: 2.3B Q4 '19: 2.3B Q1 '20: 2.3B Q2 '20: 2.3B Q3 '20: 2.4B Q4 '20: 2.5B Q1 '21: 2.7B Q2 '21: 2.9B Q3 '21: 3B Q4 '21: 2.9B Q1 '22: 2.9B Q2 '22: 2.9B Q3 '22: 2.8B Q4 '22: 2.8B Q1 '23: 2.8B Q2 '23: 2.8B Q3 '23: 2.7B Q4 '23: 2.7B Q1 '24: 2.6B Q2 '24: 2.6B Q3 '24: 2.6B Q4 '24: 2.6B Q1 '25: 2.5B Q2 '25: 2.6B Q3 '25: 2.6B Q4 '25: 2.6B Q1 '26: 2.6B Q2 '26: 2.6B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 600M 1.2B 1.8B Q3 '16: 1.1B Q4 '16: 1.1B Q1 '17: 1.1B Q2 '17: 1.1B Q3 '17: 1.2B Q4 '17: 1.2B Q1 '18: 1.2B Q2 '18: 1.2B Q3 '18: 1.2B Q4 '18: 1.2B Q1 '19: 1.2B Q2 '19: 1.2B Q3 '19: 1.3B Q4 '19: 1.3B Q1 '20: 1.3B Q2 '20: 1.2B Q3 '20: 1.3B Q4 '20: 1.4B Q1 '21: 1.5B Q2 '21: 1.6B Q3 '21: 1.7B Q4 '21: 1.6B Q1 '22: 1.6B Q2 '22: 1.6B Q3 '22: 1.6B Q4 '22: 1.6B Q1 '23: 1.5B Q2 '23: 1.5B Q3 '23: 1.5B Q4 '23: 1.4B Q1 '24: 1.4B Q2 '24: 1.4B Q3 '24: 1.4B Q4 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.3B Q3 '25: 1.3B Q4 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.3B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

0 200M 400M 600M Q4 '14: 150M Q1 '15: 163.9M Q2 '15: 158.4M Q3 '15: 157.8M Q4 '15: 166.7M Q1 '16: 158.1M Q2 '16: 140.4M Q3 '16: 135.8M Q4 '16: 48.1M Q1 '17: 48.6M Q2 '17: 24.4M Q3 '17: 35.1M Q4 '17: 109.2M Q1 '18: 126.6M Q2 '18: 172.1M Q3 '18: 169.6M Q4 '19: 229.7M Q1 '20: 247.4M Q2 '20: 242.8M Q3 '20: 294.9M Q4 '20: 421.3M Q1 '21: 447.8M Q2 '21: 520.9M Q3 '21: 568.1M Q4 '21: 500.3M Q1 '22: 545.9M Q2 '22: 544M Q3 '22: 481.8M Q4 '22: 482.6M Q1 '23: 398.1M Q2 '23: 364.8M Q3 '23: 361.1M Q4 '23: 337.8M Q1 '24: 320.5M Q2 '24: 332.4M Q3 '24: 305.9M Q4 '24: 268.9M Q1 '25: 248M Q2 '25: 223.6M Q3 '25: 224.4M Q4 '15 Q1 '17 Q2 '18 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Net Income TTM

-7.5B -5B -2.5B 0 2.5B 5B 7.5B Q3 '16: 98.2M Q4 '16: 30M Q1 '17: 30.1M Q2 '17: 17.2M Q3 '17: 20.8M Q4 '17: 122.2M Q1 '18: 766.6M Q2 '18: 1B Q3 '18: 1.3B Q4 '18: 365.6M Q1 '19: 574.1M Q2 '19: 904.8M Q3 '19: 376.7M Q4 '19: 1.8B Q1 '20: 1.6B Q2 '20: 1.9B Q3 '20: 3.5B Q4 '20: 3.8B Q1 '21: 4.1B Q2 '21: 4B Q3 '21: 6.7B Q4 '21: 4.2B Q1 '22: -97.4M Q2 '22: -1.9B Q3 '22: -6B Q4 '22: -3.6B Q1 '23: -191.3M Q2 '23: -428.4M Q3 '23: -159.3M Q4 '23: -637.3M Q1 '24: -322.4M Q2 '24: -1.3B Q3 '24: -778.7M Q4 '24: -1.8B Q1 '25: -2.2B Q2 '25: 319.2M Q3 '25: -675.9M Q4 '25: 759.9M Q1 '26: 168.8M Q2 '26: 222.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 500M 1B 1.5B Q4 '17: 972.5M Q1 '18: 991.8M Q2 '18: 1B Q3 '18: 1.1B Q4 '18: 1.1B Q1 '19: 1.1B Q2 '19: 1B Q3 '19: 1B Q4 '19: 1.1B Q1 '20: 1.1B Q2 '20: 1B Q3 '20: 1.1B Q4 '20: 1.1B Q1 '21: 1.2B Q2 '21: 1.3B Q3 '21: 1.3B Q4 '21: 1.3B Q1 '22: 1.3B Q2 '22: 1.2B Q3 '22: 1.2B Q4 '22: 1.2B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.3B Q4 '23: 1.2B Q1 '24: 1.2B Q2 '24: 1.2B Q3 '24: 1.2B Q4 '24: 1.2B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

0 300M 600M 900M Q3 '16: 157.3M Q4 '16: 216.1M Q1 '17: 167.3M Q2 '17: 152.7M Q3 '17: 129.5M Q4 '17: 104.1M Q1 '18: 200.7M Q2 '18: 216M Q3 '18: 249.8M Q4 '18: 285.5M Q1 '19: 288.1M Q2 '19: 365.6M Q3 '19: 403.1M Q4 '19: 457.9M Q1 '20: 477.8M Q2 '20: 414.5M Q3 '20: 450.4M Q4 '20: 585M Q1 '21: 635.8M Q2 '21: 698.3M Q3 '21: 793M Q4 '21: 669.5M Q1 '22: 606.3M Q2 '22: 505M Q3 '22: 285.7M Q4 '22: 194.4M Q1 '23: 242M Q2 '23: 286.8M Q3 '23: 373.5M Q4 '23: 374.9M Q1 '24: 346.6M Q2 '24: 346.1M Q3 '24: 412M Q4 '24: 455.2M Q1 '25: 515.3M Q2 '25: 534.2M Q3 '25: 491.5M Q4 '25: 532.2M Q1 '26: 510.4M Q2 '26: 492.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-250M 0 250M 500M 750M Q3 '16: 33M Q4 '16: 74.6M Q1 '17: 11.8M Q2 '17: 3.1M Q3 '17: -853K Q4 '17: -7.2M Q1 '18: 101.5M Q2 '18: 115.8M Q3 '18: 147.8M Q4 '18: 155.7M Q1 '19: 161.8M Q2 '19: 243.9M Q3 '19: 272.3M Q4 '19: 359.4M Q1 '20: 381.3M Q2 '20: 322.1M Q3 '20: 369.1M Q4 '20: 476.4M Q1 '21: 529.3M Q2 '21: 586.5M Q3 '21: 666.5M Q4 '21: 535.7M Q1 '22: 459.1M Q2 '22: 363.8M Q3 '22: 151.5M Q4 '22: 81.6M Q1 '23: 126.6M Q2 '23: 154.1M Q3 '23: 224.3M Q4 '23: 218.2M Q1 '24: 185.4M Q2 '24: 177.3M Q3 '24: 247M Q4 '24: 289.6M Q1 '25: 355.5M Q2 '25: 371M Q3 '25: 336.8M Q4 '25: 374.6M Q1 '26: 357.2M Q2 '26: 353.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '13: 28.9M Q3 '13: 28.6M Q1 '14: 29.1M Q2 '14: 29.1M Q3 '14: 29.1M Q1 '15: 29.3M Q2 '15: 29.4M Q3 '15: 29.4M Q1 '16: 29.5M Q2 '16: 29.6M Q3 '16: 29.7M Q1 '17: 29.9M Q2 '17: 30M Q3 '17: 30.1M Q1 '18: 30.2M Q2 '18: 30.2M Q3 '18: 30.3M Q1 '19: 30.1M Q2 '19: 30.2M Q3 '19: 29.8M Q1 '20: 30.2M Q2 '20: 30.1M Q3 '20: 30.1M Q1 '21: 30.2M Q2 '21: 30.1M Q3 '21: 30.2M Q1 '22: 29.9M Q2 '22: 29.8M Q3 '22: 29.7M Q1 '23: 29.7M Q2 '23: 29.4M Q3 '23: 29.2M Q1 '24: 28.5M Q2 '24: 28.4M Q3 '24: 28M Q1 '25: 28M Q2 '25: 27.2M Q3 '25: 26.9M Q1 '26: 27M Q2 '26: 26.8M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-240.00 -160.00 -80.00 0.00 80.00 160.00 240.00 Q3 '16: 3.33 Q4 '16: 1.02 Q1 '17: 1.01 Q2 '17: 0.57 Q3 '17: 0.68 Q4 '17: 4.06 Q1 '18: 25.42 Q2 '18: 34.12 Q3 '18: 42.28 Q4 '18: 11.80 Q1 '19: 18.77 Q2 '19: 29.76 Q3 '19: 12.19 Q4 '19: 58.23 Q1 '20: 52.21 Q2 '20: 64.50 Q3 '20: 116.82 Q4 '20: 126.32 Q1 '21: 135.98 Q2 '21: 134.15 Q3 '21: 220.47 Q4 '21: 140.12 Q1 '22: -4.76 Q2 '22: -66.20 Q3 '22: -201.64 Q4 '22: -121.32 Q1 '23: -6.50 Q2 '23: -14.97 Q3 '23: -5.85 Q4 '23: -21.49 Q1 '24: -10.36 Q2 '24: -47.03 Q3 '24: -27.33 Q4 '24: -65.04 Q1 '25: -76.20 Q2 '25: 11.73 Q3 '25: -24.31 Q4 '25: 27.65 Q1 '26: 5.81 Q2 '26: 7.99 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.